Pharsight

KRKA TOVARNA ZDRAVIL DD NOVO MESTO patents facing oppositions

Top patents of KRKA TOVARNA ZDRAVIL DD NOVO MESTO facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2588090B2 19 Apr, 2017 Pharmaceutical oral dosage forms comprising dabigatran etexilate and its pharmaceutically acceptable salts NA 3
EP2585051B2 31 May, 2017 Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts NA 1